DK1007093T3 - Behandling af forstyrrelser under anvendelse af inter-leukin-9 - Google Patents
Behandling af forstyrrelser under anvendelse af inter-leukin-9Info
- Publication number
- DK1007093T3 DK1007093T3 DK97939680T DK97939680T DK1007093T3 DK 1007093 T3 DK1007093 T3 DK 1007093T3 DK 97939680 T DK97939680 T DK 97939680T DK 97939680 T DK97939680 T DK 97939680T DK 1007093 T3 DK1007093 T3 DK 1007093T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- leukin
- disorders
- inter
- thyroiditis
- Prior art date
Links
- 102000000585 Interleukin-9 Human genes 0.000 title abstract 2
- 108010002335 Interleukin-9 Proteins 0.000 title abstract 2
- 229940118526 interleukin-9 Drugs 0.000 title abstract 2
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 206010043778 thyroiditis Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/206—IL-9
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2026—IL-4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pulmonology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/706,302 US5830454A (en) | 1996-08-30 | 1996-08-30 | Method for treating cell mediated autoimmune disorders using interleukin-9 |
| PCT/US1997/015264 WO1998008545A1 (fr) | 1996-08-30 | 1997-08-29 | Methodes de traitement de troubles a l'aide d'interleukine-9 et de ses antagonistes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1007093T3 true DK1007093T3 (da) | 2004-01-26 |
Family
ID=24837006
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK97939680T DK1007093T3 (da) | 1996-08-30 | 1997-08-29 | Behandling af forstyrrelser under anvendelse af inter-leukin-9 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US5830454A (fr) |
| EP (1) | EP1007093B1 (fr) |
| JP (1) | JP2000517322A (fr) |
| AT (1) | ATE252911T1 (fr) |
| AU (1) | AU721908B2 (fr) |
| CA (1) | CA2263935A1 (fr) |
| DE (1) | DE69725897T2 (fr) |
| DK (1) | DK1007093T3 (fr) |
| ES (1) | ES2210569T3 (fr) |
| PT (1) | PT1007093E (fr) |
| WO (1) | WO1998008545A1 (fr) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US20040049014A1 (en) * | 1988-12-28 | 2004-03-11 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US5830454A (en) * | 1996-08-30 | 1998-11-03 | Ludwig Institute For Cancer Research | Method for treating cell mediated autoimmune disorders using interleukin-9 |
| AU5532098A (en) * | 1996-12-20 | 1998-07-17 | Magainin Pharmaceuticals, Inc. | A method for diagnosis and treatment of inflammatory bowel diseases including crohn's disease and chronic ulcerative colitis |
| US6328955B1 (en) * | 2000-01-25 | 2001-12-11 | Ludwig Institute For Cancer Research | Method for regulating IL-10 with IL-9, and applications thereof |
| US6586336B2 (en) | 2001-08-31 | 2003-07-01 | Oriol, Inc. | Chemical-mechanical-polishing station |
| AU2003226065B2 (en) * | 2002-04-12 | 2009-02-26 | Ludwig Institute For Cancer Research, Ltd | Recombinant anti-interleukin-9 antibodies |
| GB0526000D0 (en) * | 2005-12-21 | 2006-02-01 | Ares Trading Sa | Cytokine receptor |
| WO2012129394A2 (fr) | 2011-03-22 | 2012-09-27 | Brigham And Women's Hospital, Inc. | Procédés et compositions pour le traitement du cancer |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5587302A (en) * | 1988-09-19 | 1996-12-24 | Ludwig Institute For Cancer Research | T cell growth factor |
| US5580753A (en) * | 1989-05-23 | 1996-12-03 | Ludwig Institute For Cancer Research | DNA encoding the human cytokine, interleukin-9 |
| US5414071A (en) * | 1989-05-23 | 1995-05-09 | Genetics Institute, Inc. | Human cytokine IL-9 |
| AU7552691A (en) * | 1990-03-23 | 1991-10-21 | GSF-Institut Fur Experimentalle Hamatologie | Method for enhanced growth and proliferation of mast cells |
| US5246701A (en) * | 1990-10-05 | 1993-09-21 | Ludwig Institute For Cancer Research | Method for inhibiting production of IgE by using IL-9 inhibitors |
| US5132109A (en) * | 1990-10-05 | 1992-07-21 | Ludwig Institute For Cancer Research | Method for inhibiting production of ige and method for enhancing production of igg using interleukin 9 and inhibitors thereof |
| DK0846173T3 (da) * | 1995-08-24 | 2006-01-16 | Genaera Corp | Anvendelse af et anti-interleukin-9-antistof til fremstilling af et lægemiddel til behandling af astma |
| US5830454A (en) * | 1996-08-30 | 1998-11-03 | Ludwig Institute For Cancer Research | Method for treating cell mediated autoimmune disorders using interleukin-9 |
-
1996
- 1996-08-30 US US08/706,302 patent/US5830454A/en not_active Expired - Fee Related
-
1997
- 1997-08-29 CA CA002263935A patent/CA2263935A1/fr not_active Abandoned
- 1997-08-29 JP JP10511972A patent/JP2000517322A/ja active Pending
- 1997-08-29 PT PT97939680T patent/PT1007093E/pt unknown
- 1997-08-29 WO PCT/US1997/015264 patent/WO1998008545A1/fr not_active Ceased
- 1997-08-29 AU AU41712/97A patent/AU721908B2/en not_active Ceased
- 1997-08-29 DK DK97939680T patent/DK1007093T3/da active
- 1997-08-29 EP EP97939680A patent/EP1007093B1/fr not_active Expired - Lifetime
- 1997-08-29 DE DE69725897T patent/DE69725897T2/de not_active Expired - Lifetime
- 1997-08-29 ES ES97939680T patent/ES2210569T3/es not_active Expired - Lifetime
- 1997-08-29 AT AT97939680T patent/ATE252911T1/de not_active IP Right Cessation
- 1997-09-08 US US08/925,348 patent/US5935929A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU721908B2 (en) | 2000-07-20 |
| WO1998008545A1 (fr) | 1998-03-05 |
| ES2210569T3 (es) | 2004-07-01 |
| EP1007093A4 (fr) | 2000-11-08 |
| AU4171297A (en) | 1998-03-19 |
| EP1007093B1 (fr) | 2003-10-29 |
| ATE252911T1 (de) | 2003-11-15 |
| US5935929A (en) | 1999-08-10 |
| DE69725897T2 (de) | 2004-08-26 |
| DE69725897D1 (de) | 2003-12-04 |
| EP1007093A1 (fr) | 2000-06-14 |
| US5830454A (en) | 1998-11-03 |
| CA2263935A1 (fr) | 1998-03-05 |
| PT1007093E (pt) | 2004-03-31 |
| JP2000517322A (ja) | 2000-12-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0880350T3 (da) | Behandling af dissemineret sklerose | |
| DE69532961D1 (de) | Verwendung von porphyrine in der behandlung von multiple sklerose | |
| ATE250412T1 (de) | Muskarinische antagonisten zur behandlung von presbyopie | |
| EA200601059A1 (ru) | Сложные моноэфиры пробукола для лечения сердечно-сосудистых и воспалительных заболеваний | |
| ATE207356T1 (de) | Verwendung von tiagabin zur behandlung von schlafstörungen | |
| DK0739212T3 (da) | Anvendelse af interleukin-12 til forebyggelse af transplantat-vs.-værtssygdom | |
| PL331325A1 (en) | Isobutylgabe and its derivatives useful in relieving pains | |
| DK0750507T3 (da) | Regulering af NF-kappa-B's virkning gennem proteasomet | |
| BR9709068A (pt) | Processo de tratamento. | |
| DK1007093T3 (da) | Behandling af forstyrrelser under anvendelse af inter-leukin-9 | |
| ATE233557T1 (de) | Verwendung von konjugiertes linolensäure zur steigerung der aktivität von natural killer- lymphozyten | |
| NO20002649D0 (no) | Anvendelse av en blanding av diol og en alfa-hydroksysyre for behandling av hyperkeratotiske hudsykdommer | |
| UA37199C2 (uk) | Алкіламінокетони | |
| EA199800866A1 (ru) | Способ снятия боли | |
| DK0752884T3 (da) | Fremgangsmåde til behandling af auto-immune sygdomme ved anvendelse af type 1 interferoner | |
| DE69518438D1 (de) | Behandlung von übereregten nervenzellenfunktionen | |
| KR880701687A (ko) | 하수 및 타불순물 포함수를 처리하는 방법 | |
| EP0255224A3 (fr) | Analogues cycliques et pontés cycliques du somatostatin utilisable comme médicaments analgésiques | |
| EP0904094A4 (fr) | Traitement de maladies osseuses au moyen d'adrenomedulline | |
| RU95116393A (ru) | Способ лечения заболеваний спинного мозга | |
| ATE216884T1 (de) | Verwendung von sulbutiamin zur behandlung von psychomotorischen oder psychointellektuellen beschwerden | |
| RU93039401A (ru) | Электрострессопсихотерапия | |
| DK0900085T3 (da) | Behandling af overdreven aggression med olanzapin | |
| EP0668771A4 (fr) | Traitement des maladies autoimmunes par induction d'une tolerance des cellules, des tissus et des organes. | |
| EP0444931A3 (en) | Use of 3-oxygermylpropionic acid to treat and prevent diabetes-dependent autoimmune diseases |